Rocket Lab (RKLB) Shares Jumped, What Is Behind The Latest Attention?

Rocket Lab (RKLB) grabbed investor attention after a bullish analyst note coincided with fresh operational milestones, including its 96th successful Electron mission, progress toward the maiden Neutron launch, and the planned Iridium acquisition.

The bullish commentary and fresh mission wins arrived after a choppy spell for Rocket Lab, with the share price down 26.5% over the past 90 days and 8% year to date, even as the 1-year total shareholder return is 40% and the 3-year total shareholder return is about 15x. This signals long-term momentum that recent volatility has not fully erased.

Scan other space and defense stocks showing similar contract momentum and backlog strength using our hand picked 17 high quality undiscovered gems as you size up Rocket Lab’s latest catalysts.

Rocket Lab has a long streak of wins, a sharp recent pullback, and a fresh bullish analyst target on the table. Are investors still early here, or did most of the upside already happen?

Most Popular Narrative: 18% Undervalued

Rocket Lab’s most followed valuation story pegs fair value at $85.04 per share, above the recent $69.89 close, which frames current pricing as a discount that still assumes real execution risk.

Rocket Lab is mid transformation from a small launch specialist into a vertically integrated space and defense prime, with Space Systems now ~67% of revenue and growing fastest.

A $1.85b backlog (+73% YoY) anchored by the $816m SDA Tranche 3 award provides multi-year revenue visibility that the current trailing P/S of ~72x does not yet fully reflect.

See why 93 investors see Rocket Lab as 18% undervalued.

Result: Fair Value of $85.04 (UNDERVALUED)

Still, the Rocket Lab story can break if Neutron timing slips again or if defense customers delay that US$1.85b backlog into later years.

Find out about the key risks to this Rocket Lab narrative.

Next Steps

Sentiment across Rocket Lab is split between concern and optimism, so move quickly and review the evidence for yourself. Then weigh both sides and ground your own thesis with the 2 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Rocket Lab?

If Rocket Lab has your attention, do not stop there. Broaden your watchlist with other opportunities that fit clear, disciplined criteria using targeted screeners.

• Target resilient compounding potential by focusing on strong balance sheets and consistent fundamentals through our curated list of solid balance sheet and fundamentals (23 results).
• Hunt for quality at a sensible entry point by filtering for businesses that score well on fundamentals using the 30 high quality undervalued stocks.
• Lock in reliable cash returns by zeroing in on income focused opportunities through a hand picked set of 7 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com